奥瑞许科技 OSUR 深 沪
等待开盘 03-26 09:30:00 美东时间
3.14
+0.080
+2.61%
华盛通- 最 高3.175
- 今 开3.13
- 成交量 42.46万股
- 最 低 3.07
- 昨 收 3.06
- 总市值 2.17亿
- 52周最高 3.82
- 市盈率 静 --
- 换手率 0.61%
- 52周最低 2.08
- 委 比 -74.07%
- 总股本 6912.62万
- 历史最高 23.01
- 量 比 0.50
- 振 幅 3.43%
- 历史最低 2.08
- 每 手 1
- 风险率 0.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Activist Altai Capital pushes for OraSure sale, board seats
Activist investor Altai Capital is pushing for OraSure Technologies (OSUR) to pursue a potential sale that could result in the doubling of the medical device maker's share price. OraSure (OSUR) may be...
03-17 23:44
OraSure CFO Kenneth J. McGrath acquires USD 66,038 of common shares
OraSure CFO Kenneth J. McGrath acquires USD 66,038 of common shares Kenneth McGrath, Chief Financial Officer of OraSure Technologies, acquired 22,021 common shares at a weighted average price of USD 3 per share. Following the acquisition, McGrath beneficially owned 557,262 common shares. Disclaimer:
03-17 08:02
OraSure President and CEO Carrie Eglinton Manner acquires USD 66,000 of common shares
OraSure President and CEO Carrie Eglinton Manner acquires USD 66,000 of common shares Carrie Eglinton Manner, President and CEO of OraSure Technologies, acquired 22,022 common shares at a weighted average price of USD 3.00 per share. Following the acquisition, she beneficially owned 2,158,574 common
03-17 08:02
OraSure Technologies shares are trading higher after the company reported better-than-expected Q4 financial results.
OraSure Technologies shares are trading higher after the company reported bette...
02-27 01:00
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches
Earnings Call Insights: OraSure Technologies (OSUR) Q4 2025 Management View Carrie Eglinton Manner, President and CEO, stated that "2025 was a transition year, and we supported our customers in naviga...
02-26 09:18
OraSure Technologies Q4 Adj. EPS $(0.19) Beats $(0.20) Estimate, Sales $26.763M Beat $26.443M Estimate
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 7.32 percent. This is a 216.67 percent decrease over losses of $(0.06) per share
02-26 05:14
Earnings Scheduled For February 25, 2026
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
奥瑞许科技2025年上半年财务、融资及评级动态
经济观察网 基于截至2025年6月的公开信息，奥瑞许科技（OSUR.US）值得关注的事件主要包括财务表现、公司行动及分析师评级。具体如下： 业绩经营情况 20...
02-20 08:37
OraSure Technologies Announced Its OraQuick HIV Self-Test Has Received License From Health Canada
The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada's first oral HIV self-test and detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV status
02-10 21:16
Health Canada erteilt OraSure Technologies Zulassung für OraQuick HIV-Selbsttest
Health Canada erteilt OraSure Technologies Zulassung für OraQuick HIV-Selbsttest OraSure Technologies Inc. hat bekannt gegeben, dass der OraQuick HIV Selbsttest eine Zulassung von Health Canada für die Verwendung in Kanada erhalten hat. Der Test ist der erste orale HIV-Selbsttest in Kanada und ermög
02-10 21:05
